Service d'immunologie et d'allergie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1804 publications

... | 2015 | 2014 | 2013 | 2012 | 2011 | ...
2015
Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.
Ott de Bruin L.M., Volpi S., Musunuru K., 2015. Frontiers In Immunology, 6 p. 250. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FEDC491D3112]
Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds.
Yang W.L., Kouyos R.D., Böni J., Yerly S., Klimkait T., Aubert V., Scherrer A.U., Shilaih M., Hinkley T., Petropoulos C. et al., 2015. Plos Pathogens, 11 (3) pp. e1004722. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1A9CA68C13F2]
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases - a longitudinal study.
Fischer L., Gerstel P.F., Poncet A., Siegrist C.A., Laffitte E., Gabay C., Seebach J.D., Ribi C., 2015. Arthritis Research and Therapy, 17 p. 151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_935C40DB3F76]
 
Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: A cross-sectional study of two cohorts.
Koenig K.F., Ribi C., Radosavac M., Zulewski H., Trendelenburg M., Swiss SLE cohort study (SSCS), 2015. Lupus, 24 (1) pp. 58-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8A0D788B2ACA]
Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.
Rissone A., Weinacht K.G., la Marca G., Bishop K., Giocaliere E., Jagadeesh J., Felgentreff K., Dobbs K., Al-Herz W., Jones M. et al., 2015. Journal of Experimental Medicine, 212 (8) pp. 1185-1202. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_43128B927D92]
 
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection.
Cubas R., van Grevenynghe J., Wills S., Kardava L., Santich B.H., Buckner C.M., Muir R., Tardif V., Nichols C., Procopio F. et al., 2015. Journal of Immunology, 195 (12) pp. 5625-5636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8DF366DBE66A]
S100B Up-Regulates Macrophage Production of IL1beta and CCL22 and Influences Severity of Retinal Inflammation
Niven J., Hoare J., McGowan D., Devarajan G., Itohara S., Gannage M., Teismann P., Crane I., 2015. PLoS One, 10 (7) pp. e0132688.
[URN][DOI][Pmid][serval:BIB_7235548BE398]
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
Spertini F., Audran R., Chakour R., Karoui O., Steiner-Monard V., Thierry A.C., Mayor C.E., Rettby N., Jaton K., Vallotton L. et al., 2015. Lancet. Respiratory Medicine, 3 (12) pp. 953-962. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DEC0014ACCA2]
Schistosoma mansoni and HIV acquisition in fishing communities of Lake Victoria, Uganda: a nested case-control study.
Ssetaala A., Nakiyingi-Miiro J., Asiki G., Kyakuwa N., Mpendo J., Van Dam G.J., Corstjens P.L., Pala P., Nielsen L., Bont J. et al., 2015. Tropical Medicine and International Health, 20 (9) pp. 1190-1195. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFE5F4BAAACE]
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
Vionnet J., Pascual M., Chtioui H., Giostra E., Majno P.E., Decosterd L.A., Moradpour D., 2015. BMC Gastroenterology, 15 (1) p. 38. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2416C6CBDE27]
 
Syndromes myélodysplasiques et auto-immunité [Myelodysplastic syndromes and autoimmunity].
Stalder G., Alberio L., Ribi C., 2015. Revue Médicale Suisse, 11 (469) pp. 820-2, 824-5.
[Pmid][serval:BIB_2652D42C3E88]
 
Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.
Mooij P., Koopman G., Drijfhout J.W., Nieuwenhuis I.G., Beenhakker N., Koestler J., Bogers W.M., Wagner R., Esteban M., Pantaleo G. et al., 2015. Journal of General Virology, 96 (Pt 6) pp. 1478-1483. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_295841777C34]
 
T cells as a therapeutic target in SLE.
Comte D., Karampetsou M.P., Tsokos G.C., 2015. Lupus, 24 (4-5) pp. 351-363. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF302EF01784]
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
Søgaard O.S., Graversen M.E., Leth S., Olesen R., Brinkmann C.R., Nissen S.K., Kjaer A.S., Schleimann M.H., Denton P.W., Hey-Cunningham W.J. et al., 2015. Plos Pathogens, 11 (9) pp. e1005142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CFC707BF32ED]
 
Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation.
Yerly P., Rotman S., Nobile A., Aubert V., Tozzi P., Yarol N., Vogt P., Hullin R., Pascual M., 2015. Transplantation, 99 (3) pp. 586-593.
[DOI][WoS][Pmid][serval:BIB_D6262E122241]
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases
Bühler S., Eperon G., Ribi C., Kyburz D., van Gompel F., Visser L.G., Siegrist C.A., Hatz C., 2015. Swiss Medical Weekly, 145 pp. w14159. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3C53DF1586B]
 
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.
Shen X., Duffy R., Howington R., Cope A., Sadagopal S., Park H., Pal R., Kwa S., Ding S., Yang O.O. et al., 2015. Journal of Virology, 89 (16) pp. 8643-8650. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1DE3F28356D7]
 
Virological and Immunological Characterization of Novel NYVAC-Based HIV/AIDS Vaccine Candidates Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as Virus-Like Particles.
Perdiguero B., Gómez C.E., Cepeda V., Sánchez-Sampedro L., García-Arriaza J., Mejías-Pérez E., Jiménez V., Sánchez C., Sorzano C.Ó., Oliveros J.C. et al., 2015. Journal of Virology, 89 (2) pp. 970-988. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5051C6A40F15]
2014
 
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Terrier B., Pagnoux C., Mouthon L., Guillevin L. et al., 2014/09. Autoimmunity reviews, 13 (9) pp. 945-953. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C14F9BAB68A8]
 
Transplantation cellulaire: traitements actuels et perspectives d'avenir [Cell transplantation: current treatments and future prospects]
Meier R.P., Muller Y.D., Gutzwiller E.M., Spahr L., Negro F., Krause K.H., Schaller K., Wandrey C., Sgroi A., Morel P. et al., 2014/06/18. Revue medicale suisse, 10 (435) pp. 1350-1355. Peer-reviewed.
[Pmid][serval:BIB_7F267F2C10D3]
 
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Jilek S., Mathias A., Canales M., Lysandropoulos A., Pantaleo G., Schluep M., Du Pasquier R.A., 2014/06. Multiple sclerosis (Houndmills, Basingstoke, England), 20 (7) pp. 837-842. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75F2F83A31AE]
 
Anaphylaxie aux colorants bleus [Anaphylaxis to blue dyes]
Langner-Viviani F., Chappuis S., Bergmann M.M., Ribi C., 2014/04/16. Revue medicale suisse, 10 (426) pp. 876-880. Peer-reviewed.
[Pmid][serval:BIB_5D23836C01B0]
 
A 3 years retrospective study of survival for zirconia-based single crowns fabricated from intraoral digital impressions.
Gherlone E., Mandelli F., Capparè P., Pantaleo G., Traini T., Ferrini F., 2014. Journal of Dentistry, 42 (9) pp. 1151-1155. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BEAA31E109D6]
 
Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response.
Abed J., Lebreton C., Champier G., Cuvillier A., Cogné M., Meresse B., Dugave C., Garfa-Traoré M., Corthésy B., Cerf-Bensussan N. et al., 2014. Mucosal Immunology, 7 (2) pp. 315-324.
[DOI][WoS][Pmid][serval:BIB_446C2D461B92]
 
Adverse reactions to biologic agents and their medical management.
Boyman O., Comte D., Spertini F., 2014. Nature Reviews. Rheumatology, 10 (10) pp. 612-627. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_897931CEA415]
 
Allergie ou intolérance alimentaire [Food allergy or food intolerance?].
Maître S., Maniu C.M., Buss G., Maillard M.H., Spertini F., Ribi C., 2014. Revue Médicale Suisse, 10 (426) pp. 846-50, 852-3.
[Pmid][serval:BIB_4716A2B9CE96]
 
Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation.
Keck S., Schmaler M., Ganter S., Wyss L., Oberle S., Huseby E.S., Zehn D., King C.G., 2014. Proceedings of the National Academy of Sciences of the United States of America, 111 (41) pp. 14852-14857. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF0A16730221]
Autoimmunity-Associated LYP-W620 Does Not Impair Thymic Negative Selection of Autoreactive T Cells.
Wu D.J., Zhou W., Enouz S., Orrú V., Stanford S.M., Maine C.J., Rapini N., Sawatzke K., Engel I., Fiorillo E. et al., 2014. Plos One, 9 (2) pp. e86677. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B910F6EFBB15]
 
Bivalent NYVAC-based Vaccine Candidates against HIV/AIDS Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as VLPs.
Perdiguero B., Gómez C.E., Cepeda M.V., Sánchez-Sampedro L., García-Arriaza J., Mejías-Pérez E., Jiménez V., Sánchez C., Sorzano C.O., Delaloye J. et al., 2014. pp. A119 dans Aids Research and Human Retroviruses. Peer-reviewed.
[DOI][Pmid][serval:BIB_A173C82FBCD3]
 
Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies.
Cortese A., Pantaleo G., Ferrara I., Vatrella A., Cozzolino I., Di Crescenzo V., Amato M., 2014. International journal of surgery (London, England), 12 Suppl 2 pp. S23-8.
[DOI][Pmid][serval:BIB_2764F2755C75]
CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression.
Viganò S., Banga R., Bellanger F., Pellaton C., Farina A., Comte D., Harari A., Perreau M., 2014. Plos Pathogens, 10 (9) pp. e1004380. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C7F89A3A803E]
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV.
Kouyos R.D., Rauch A., Böni J., Yerly S., Shah C., Aubert V., Klimkait T., Kovari H., Calmy A., Cavassini M. et al., 2014. International Journal of Epidemiology, 43 (3) pp. 887-896. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5CB4ED53653]
Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
Perrin Y., Nutten S., Audran R., Berger B., Bibiloni R., Wassenberg J., Barbier N., Aubert V., Moulin J., Singh A. et al., 2014. Clinical and Translational Allergy, 4 (1) p. 1. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9517E7BEF541]
Differences in the transduction of canonical wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
Boudousquié C., Danilo M., Pousse L., Jeevan-Raj B., Angelov G.S., Chennupati V., Zehn D., Held W., 2014. Journal of Immunology, 193 (6) pp. 2784-2791. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1CEC9FA289EB]
Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.
Perreau M., Vigano S., Bellanger F., Pellaton C., Buss G., Comte D., Roger T., Lacabaratz C., Bart P.A., Levy Y. et al., 2014. Journal of Experimental Medicine, 211 (10) pp. 2033-2045. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C2E49D53264]
Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests.
Vetter B.N., Orlowski V., Fransen K., Niederhauser C., Aubert V., Brandenberger M., Ciardo D., Dollenmaier G., Klimkait T., Regenass S. et al., 2014. Plos One, 9 (10) pp. e111552.
[URN][DOI][WoS][Pmid][serval:BIB_1781BD45F2A9]
Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide.
Kouyos R.D., Rauch A., Braun D.L., Yang W.L., Böni J., Yerly S., Klimkait T., Aubert V., Shah C., Kovari H. et al., 2014. Journal of Infectious Diseases, 210 (10) pp. 1555-1561. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C8882041D20F]
 
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.
Muyanja E., Ssemaganda A., Ngauv P., Cubas R., Perrin H., Srinivasan D., Canderan G., Lawson B., Kopycinski J., Graham A.S. et al., 2014. Journal of Clinical Investigation, 124 (7) pp. 3147-3158.
[DOI][WoS][Pmid][serval:BIB_A388598F9F16]
Increased Presence of FOXP3+ Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood.
Vercoulen Y., Bellutti Enders F., Meerding J., Plantinga M., Elst E.F., Varsani H., van Schieveen C., Bakker M.H., Klein M., Scholman R.C. et al., 2014. Plos One, 9 (8) pp. e105353. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ED49FCF59722]
Inflammation and TCR Signal Strength Determine the Breadth of the T Cell Response in a Bim-Dependent Manner.
Zehn D., Roepke S., Weakly K., Bevan M.J., Prlic M., 2014. Journal of Immunology, 192 (1) pp. 200-205. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7FE9BEB468C7]
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
[DOI][WoS][Pmid][serval:BIB_252EB74C8343]
 
Innate immune responses in MS: a systematic monocyte and B cell-based study
Mathias A, 2014. dans 12th ISNI Congress - November 9 – 13 Mainz, Germany.
[serval:BIB_945370164C3F]
 
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients.
Metzner K.J., Scherrer A.U., von Wyl V., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H., Hirsch H.H., Vernazza P.L. et al., 2014. Aids, 28 (15) pp. 2231-2239. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_703F652D955C]
 
Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Ruivard M., Terrier B., Pagnoux C., Mouthon L. et al., 2014. Autoimmunity Reviews, 13 (2) pp. 197-205.
[DOI][WoS][Pmid][serval:BIB_136EE4DA51CA]
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M., Marsland B.J., Gehrig J., Held W., Favre S., Luther S.A., Perroud M., Golshayan D., Gaide O., Thome M., 2014. EMBO Journal, 33 (23) pp. 2765-2781.
[URN][DOI][WoS][Pmid][serval:BIB_9401281135B4]
 
Neurologie [News in neurology 2013].
Spatola M., Rossetti A.O., Michel P., Kuntzer T., Benninger D., Nater B., Démonet J.F., Schluep M., Du Pasquier R.A., Vingerhoets F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 78-81. Peer-reviewed.
[Pmid][serval:BIB_4D7730CB34C5]
Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index.
Hoggart C.J., Venturini G., Mangino M., Gomez F., Ascari G., Zhao J.H., Teumer A., Winkler T.W., Ternikova N., Luan J. et al., 2014. PLoS Genetics, 10 (7) pp. e1004508.
[URN][DOI][WoS][Pmid][serval:BIB_B24DBE741EAD]
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
Hasse B., Iff M., Ledergerber B., Calmy A., Schmid P., Hauser C., Cavassini M., Bernasconi E., Marzolini C., Tarr P.E. et al., 2014. Open Forum Infectious Diseases, 1 (2) pp. ofu040.
[URN][DOI][Pmid][serval:BIB_44F79E67FED2]
 
Optimal T-cell receptor affinity for inducing autoimmunity.
Koehli S., Naeher D., Galati-Fournier V., Zehn D., Palmer E., 2014. Proceedings of the National Academy of Sciences of the United States of America, 111 (48) pp. 17248-17253. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD34E5F30032]
 
Place de l'enseignement à distance dans l'éducation et la formation du chercheur [Role of distance learning in the education and the training of the investigator].
Rossier B.C., Kraehenbuhl J.P., Rossier M., 2014. Médecine Sciences : M/s, 30 (6-7) pp. 603-604. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA80CEB9C045]
Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
Balam S., Olugbile S., Servis C., Diakité M., D'Alessandro A., Frank G., Moret R., Nebie I., Tanner M., Felger I. et al., 2014. Malaria Journal, 13 p. 510.
[URN][DOI][WoS][Pmid][serval:BIB_2CED1904C6D2]
 
Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen.
Longet S., Vonarburg C., Lötscher M., Miescher S., Zuercher A., Corthésy B., 2014. Journal of Biological Chemistry, 289 (31) pp. 21617-21626. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_370FB568BF12]
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E., Bibert S., Duong F.H., Krol I., Jørgensen S., Collinet E., Kutalik Z., Aubert V., Cerny A., Kaiser L. et al., 2014. Nature Communications, 5 p. 5699. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_84F2B7901E6D]
 
Role of secretory IgA in the mucosal sensing of commensal bacteria
Mathias A., Pais B., Favre L., Benyacoub J., Corthesy B., 2014. Gut Microbes.
[DOI][serval:BIB_C6D3EFC77243]
 
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Pollard R.B., Rockstroh J.K., Pantaleo G., Asmuth D.M., Peters B., Lazzarin A., Garcia F., Ellefsen K., Podzamczer D., van Lunzen J. et al., 2014. Lancet Infectious Diseases, 14 (4) pp. 291-300.
[DOI][WoS][Pmid][serval:BIB_BEEE667D2F5B]
 
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
Spertini F., Perrin Y., Audran R., Pellaton C., Boudousquié C., Barbier N., Thierry A.C., Charlon V., Reymond C., 2014. Journal of Allergy and Clinical Immunology, 134 (1) pp. 239-240.e13.
[DOI][WoS][Pmid][serval:BIB_6FD3B35B8A79]
 
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
Thacher E.G., Cavassini M., Audran R., Thierry A.C., Bollaerts A., Cohen J., Demoitié M.A., Ejigu D., Mettens P., Moris P. et al., 2014. Aids, 28 (12) pp. 1769-1781. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01ED4554A2E9]
 
Social meets molecular: Combining phylogenetic and latent class analyses to understand HIV-1 transmission in Switzerland.
Avila D., Keiser O., Egger M., Kouyos R., Böni J., Yerly S., Klimkait T., Vernazza P.L., Aubert V., Rauch A. et al., 2014. American Journal of Epidemiology, 179 (12) pp. 1514-1525. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_512FB5EBF7E1]
 
T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?
Speiser D.E., Utzschneider D.T., Oberle S.G., Münz C., Romero P., Zehn D., 2014. Nature Reviews. Immunology, 14 (11) pp. 768-774.
[DOI][WoS][Pmid][serval:BIB_F1317F9BECF7]
The dysfunction of T follicular helper cells.
Cubas R., Perreau M., 2014. Current Opinion In Hiv and Aids, 9 (5) pp. 485-491. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7472C604B41]
 
The immune space: a concept and template for rationalizing vaccine development.
Manrique A., Adams E., Barouch D.H., Fast P., Graham B.S., Kim J.H., Kublin J.G., McCluskey M., Pantaleo G., Robinson H.L. et al., 2014. Aids Research and Human Retroviruses, 30 (11) pp. 1017-1022. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F5453339A90]
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C., Trendelenburg M., Gayet-Ageron A., Cohen C., Dayer E., Eisenberger U., Hauser T., Hunziker T., Leimgruber A., Lindner G. et al., 2014. Swiss Medical Weekly, 144 pp. w13990. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2974FF159755]
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Drescher S.M., von Wyl V., Yang W.L., Böni J., Yerly S., Shah C., Aubert V., Klimkait T., Taffé P., Furrer H. et al., 2014. Clinical Infectious Diseases, 58 (2) pp. 285-294.
[URN][DOI][WoS][Pmid][serval:BIB_9722D8509BAC]
 
Un cas inhabituel d'allergie au champagne [A case of unusual allergy to champagne].
Carron P.N., Vionnet J., Ribi C., Pasquier M., Hugli O., 2014. Presse Médicale, 43 (10 Pt 1) pp. 1127-1129. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_824EE412E742]
 
V3 net charge: additional tool in HIV-1 tropism prediction.
Montagna C., De Crignis E., Bon I., Re M.C., Mezzaroma I., Turriziani O., Graziosi C., Antonelli G., 2014. Aids Research and Human Retroviruses, 30 (12) pp. 1203-1212.
[DOI][WoS][Pmid][serval:BIB_E29E309DB201]
2013
 
Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system
Romao S., Gannage M., Munz C., 2013/10. Semin Cancer Biol, 23 (5) pp. 391-6.
[DOI][Pmid][serval:BIB_6890A04F4354]
 
Systemischer Lupus Erythematodes – die «Swiss SLE Cohort Study (SSCS)»
Trendelenburg Marten, Ribi Camillo, 2013/05/29. Forum Médical Suisse ‒ Swiss Medical Forum, 13 (22).
[DOI][serval:BIB_71B58D0F776F]
 
Combined analysis of mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses for the timely diagnosis of active TB disease.
Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day C, Perreau M, Lazor-Blanchet C, Petruciolli E, Hanekom W, Goletti D et al., 2013/04/18., Société Suisse d’allergologie et Société Suisse de penumologie dans Congrès annuel de la Société Suisse d’allergologie et Société Suisse de penumologie / Présentation orale / Laboratory diagnostic / 2013 Bern.
[serval:BIB_03E563DA8898]
 
Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA), polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with no initial Five-Factor Score-defined poor-prognosis factors (FFS=0): Baseline factors associated with cytotoxic agent and immunomodulator prescription
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Bienvenu B., Pagnoux C., Mouthon L., Guillevin L., 2013/04. La Presse Médicale, 42 (4) p. 666.
[DOI][WoS][serval:BIB_8CE4ADCD3172]
 
A light in the cognitive fog?
Cavassini M., Du Pasquier R.A., 2013. Antiviral Therapy, 18 (2) pp. 149-151. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0C311769084]
 
Agglutinating Secretory IgA Preserves Intestinal Epithelial Cell Integrity during Apical Infection by Shigella flexneri.
Mathias A., Longet S., Corthésy B., 2013. Infection and Immunity, 81 (8) pp. 3027-3034. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_180C05B72C99]
 
Allergies aux produits de contraste radiologiques [Allergy to radiographic contrast media].
Vionnet J., Petitpierre S., Fumeaux A., Meuli R., Spertini F., Comte D., 2013. Revue Médicale Suisse, 9 (382) pp. 812-818.
[Pmid][serval:BIB_756668CAAD30]
 
Allergologie: 1. Anti-TNFalpha: effets indésirables et implications pratiques [Management of adverse events induced by TNFalpha blocking agents].
Chappuis S., Ribi C., Spertini F., 2013. Revue Médicale Suisse, 9 (368) pp. 12-16.
[Pmid][serval:BIB_9898AE02A3E9]
 
Allergologie: 2. Mastocytose systémique--nouvelles stratégies thérapeutiques [Systemic mastocytosis--new therapeutic strategies].
Maniu C.M., Ribi C., Spertini F., 2013. Revue Médicale Suisse, 9 (368) pp. 17-21.
[Pmid][serval:BIB_D8E4A67BD0EC]
 
Allergologie: 3. Intérêts des allergènes recombinants dans la pratique de l'allergologie [Interests of recombinant allergens in the practice of allergy].
Karoui O., Leimgruber A., Spertini F., 2013. Revue Médicale Suisse, 9 (368) pp. 22-27.
[Pmid][serval:BIB_3DD81E2CCC7A]
An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
Schnegg A., Bürgisser P., André C., Kenfak-Foguena A., Canellini G., Moradpour D., Abravanel F., Izopet J., Cavassini M., Darling K.E., 2013. Plos One, 8 (5) pp. e62980.
[URN][DOI][WoS][Pmid][serval:BIB_E983ACA01A41]
 
Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl.
Ferrini W., Aubert V., Balmer A., Munier F.L., Abouzeid H., 2013. Pediatrics, 132 (4) pp. e1035-e1038. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FF98065FC2DD]
 
Anticorps antineuronaux: un domaine en plein développement [Anti-neuronal antibodies: a rapidly developing field].
Zekeridou A., Rossetti A.O., Hottinger A.F., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 909-914.
[Pmid][serval:BIB_50B33579B2CE]
 
Antigen processing for MHC presentation via macroautophagy
Gannage M., da Silva R. B., Munz C., 2013. Methods Mol Biol, 960 pp. 473-488.
[DOI][Pmid][serval:BIB_FF3B4FF6D578]
 
Assessing risks of multiple sclerosis therapies.
Parfenov V., Schluep M., Du Pasquier R., 2013. Journal of the Neurological Sciences, 332 (1-2) pp. 59-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F31492A65D5]
 
Biases on the administered parenteral doses of an experimental drug during phase I clinical trials
Perrottet Ries N., Brunner-Ferber F., Grouzmann E., Spertini F., Biollaz J., Buclin T., Widmer N., 2013. pp. e2-e3 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics. Peer-reviewed.
[DOI][serval:BIB_F78D47B7238A]
 
Biomarqueurs en immunologie générale [Biomarkers in clinical immunology].
Pardon A., Aubert V., Bart P.A., 2013. Revue Médicale Suisse, 9 (404) pp. 1982-1991.
[Pmid][serval:BIB_42627C1CB334]
Bystander-Activated Memory CD8 T Cells Control Early Pathogen Load in an Innate-like, NKG2D-Dependent Manner.
Chu T., Tyznik A.J., Roepke S., Berkley A.M., Woodward-Davis A., Pattacini L., Bevan M.J., Zehn D., Prlic M., 2013. Cell Reports, 3 (3) pp. 701-708. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A606CA61CD6C]
 
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
Lange C.M., Bibert S., Dufour J.F., Cellerai C., Cerny A., Heim M.H., Kaiser L., Malinverni R., Müllhaupt B., Negro F. et al., 2013. Journal of Hepatology, 59 (3) pp. 504-509.
[DOI][WoS][Pmid][serval:BIB_223719F6DDDB]
 
Das schweizerische HIV Testkonzept - eine akutalisierte Version. Concept suisse de test VIH: récapitulatif actualisé.
Schüpbach J., Niederhauser C., Andreutti C., Gorgievski M., Klimkait T., Martinetti G., Regenass S., Yerly S., Aubert V., Brandenberger M. et al., 2013. BAG Bulletin, 47 pp. 851-853.
[serval:BIB_2EA5EF31B11D]
Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.
Rochereau N., Drocourt D., Perouzel E., Pavot V., Redelinghuys P., Brown G.D., Tiraby G., Roblin X., Verrier B., Genin C. et al., 2013. PLoS Biology, 11 (e1001658) pp. 1-18.
[URN][DOI][WoS][Pmid][serval:BIB_A55F4DE084BF]
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C.
Perdiguero B., Gómez C.E., Di Pilato M., Sorzano C.O., Delaloye J., Roger T., Calandra T., Pantaleo G., Esteban M., 2013. Plos One, 8 (9) pp. e74831. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E338A0FB5AA2]
 
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Lauwerys B.R., Hachulla E., Spertini F., Lazaro E., Jorgensen C., Mariette X., Haelterman E., Grouard-Vogel G., Fanget B., Dhellin O. et al., 2013. Arthritis and Rheumatism, 65 (2) pp. 447-456.
[DOI][WoS][Pmid][serval:BIB_F2ED4DF576DB]
 
Eosinophilie sanguine: quel bilan, quel cheminement diagnostique [Peripheral blood eosinophilia: diagnostic value and further assessment].
Chappuis S., Ribi C., Greub G., Spertini F., 2013. Revue Médicale Suisse, 9 (382) pp. 819-825.
[Pmid][serval:BIB_07BFF61EE37B]
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
[DOI][WoS][Pmid][serval:BIB_DB6B15EEC4D0]
Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.
Perreau M., Savoye A.L., De Crignis E., Corpataux J.M., Cubas R., Haddad E.K., De Leval L., Graziosi C., Pantaleo G., 2013. Journal of Experimental Medicine, 210 (1) pp. 143-156. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6855C69852B5]
 
Formes sévères d'hypersensibilité médicamenteuse retardée [Severe delayed drug hypersensitivity reactions].
Maniu C.M., Buss G., Feldmeyer L., Spertini F., Ribi C., 2013. Revue Médicale Suisse, 9 (382) pp. 803-811.
[Pmid][serval:BIB_B7B36335E226]
Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development.
Lange C.M., Miki D., Ochi H., Nischalke H.D., Bojunga J., Bibert S., Morikawa K., Gouttenoire J., Cerny A., Dufour J.F. et al., 2013. Plos One, 8 (5) pp. e64053. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C5A41A5E2DE]
 
Human Plasma-derived Polymeric IgA and IgM Antibodies Associate with Secretory Component to Yield Biologically Active Secretory-like Antibodies.
Longet S., Miled S., Lötscher M., Miescher S.M., Zuercher A.W., Corthésy B., 2013. Journal of Biological Chemistry, 288 (6) pp. 4085-4094. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21627C17E346]
 
IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8(+) T cells.
Stark R., Hartung A., Zehn D., Frentsch M., Thiel A., 2013. European Journal of Immunology, 43 (6) pp. 1511-1517. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D851A49AA57E]
 
Immune response to HIV.
Perreau M., Levy Y., Pantaleo G., 2013. Current Opinion in HIV and Aids, 8 (4) pp. 333-340.
[DOI][WoS][Pmid][serval:BIB_C74E1437AA13]
 
Immunosuppresseurs: usages systémiques et neurologiques [Systemic and neurological uses of immunosuppressive agents].
Schnider C., Seebach J.D., Ribi C., Spertini F., 2013. Revue Médicale Suisse, 9 (384) pp. 915-921.
[Pmid][serval:BIB_6274D4C3C9C3]
 
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
Zahednasab H., 2013. Neurology, 81 (1) pp. 97-98.
[DOI][WoS][Pmid][serval:BIB_B64568DCC059]
Inadequate T follicular cell help impairs B cell immunity during HIV infection.
Cubas R.A., Mudd J.C., Savoye A.L., Perreau M., van Grevenynghe J., Metcalf T., Connick E., Meditz A., Freeman G.J., Abesada-Terk G. et al., 2013. Nature Medicine, 19 (4) pp. 494-499. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F10C91F4362C]
 
Increased ex-vivo antigen presentation profile of B cells in multiple sclerosis
Mathias A, 2013. dans MS State of the Art Symposium, Bern, Switzerland.
[serval:BIB_FD3180BD90B3]
Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells.
Legat A., Speiser D.E., Pircher H., Zehn D., Fuertes Marraco S.A., 2013. Frontiers in Immunology, 4 p. 455.
[URN][DOI][WoS][Pmid][serval:BIB_6F1D514487FB]
 
La jungle bureaucratique des patients hors liste et hors étiquette [The bureaucratic jungle of off-list and off-label patients].
Seebach J.D., Spertini F., 2013. Revue Médicale Suisse, 9 (382) pp. 795-796.
[Pmid][serval:BIB_19AB028E3BDC]
 
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4(+) T cells in active disease.
Perreau M., Rozot V., Welles H.C., Belluti-Enders F., Vigano S., Maillard M., Dorta G., Mazza-Stalder Jesica, Bart P.A., Roger T. et al., 2013. European Journal of Immunology, 43 (4) pp. 939-948.
[DOI][WoS][Pmid][serval:BIB_E956D462F256]
 
Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization.
Spring P., Vernez M., Maniu C.M., Hohl D., 2013. Dermatology Online Journal, 19 (6) p. 18572.
[Pmid][serval:BIB_A2E1DA80188C]
 
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L., Guillevin L., French Vasculitis Study Group, 2013. Journal of Autoimmunity, 43 pp. 60-69.
[DOI][WoS][Pmid][serval:BIB_C9E76490EEB2]
 
Maladie coeliaque: état des lieux [An update on celiac disease].
Godat S., Velin D., Aubert V., Nydegger A., Schoepfer A.M., Maillard M.H., 2013. Revue Médicale Suisse, 9 (396) pp. 1584-1589.
[Pmid][serval:BIB_68904038A189]
 
Maladies auto-immunes neuromusculaires: diagnostic et prise en charge [Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management].
Lalive P.H., Du Pasquier R.A., Chizzolini C., Kuntzer T., 2013. Revue Médicale Suisse, 9 (384) pp. 934-939. Peer-reviewed.
[Pmid][serval:BIB_817EBBDB2E4A]
 
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy.
Du Pasquier R.A., Jilek S., Kalubi M., Yerly S., Fux C.A., Gutmann C., Cusini A., Günthard H.F., Cavassini M., Vernazza P.L. et al., 2013. Aids, 27 (2) pp. 203-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53A5510C85E2]
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
Granziera C., Daducci A., Simioni S., Cavassini M., Roche A., Meskaldji D., Kober T., Metral M., Calmy A., Helms G. et al., 2013. Plos One, 8 (9) pp. e72547.
[URN][DOI][WoS][Pmid][serval:BIB_37E6E2376D1C]
MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer.
Dudda J.C., Salaun B., Ji Y., Palmer D.C., Monnot G.C., Merck E., Boudousquie C., Utzschneider D.T., Escobar T.M., Perret R. et al., 2013. Immunity, 38 (4) pp. 742-753. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C465F0F1D8F8]
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Jilek S., Schluep M., Pantaleo G., Du Pasquier R.A., 2013. Neurological Sciences, 34 (4) pp. 539-543.
[URN][DOI][WoS][Pmid][serval:BIB_4187CB3E957E]
Molecular insights for optimizing T cell receptor specificity against cancer.
Hebeisen M., Oberle S.G., Presotto D., Speiser D.E., Zehn D., Rufer N., 2013. Frontiers In Immunology, 4 p. 154.
[URN][DOI][WoS][Pmid][serval:BIB_5D02888E4E45]
Multi-faceted functions of secretory IgA at mucosal surfaces.
Corthésy B., 2013. Frontiers in Immunology, 4 p. 185. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EDBE117559C]
 
Multicenter evaluation of the elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.
Esteban J.I., van Helden J., Alborino F., Bürgisser P., Cellerai C., Pantaleo G., Eiras A., Rodriguez M.I., Ghisetti V., Gleich M. et al., 2013. Journal of Medical Virology, 85 (8) pp. 1362-1368.
[DOI][WoS][Pmid][serval:BIB_47F08714BB89]
 
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.
Rozot V., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Petruccioli E., Hanekom W., Goletti D. et al., 2013. European Journal of Immunology, 43 (6) pp. 1568-1577.
[DOI][WoS][Pmid][serval:BIB_7269592AD615]
 
Nadir of CD11a expression on T lymphocytes of multiple sclerosis patients after two years on natalizumab.
Mathias A, 2013. dans ECTRIMS. October 2-5. Copenhagen, Denmark.
[DOI][serval:BIB_99D551330EEA]
 
Neurologie [2012: news in neurology].
Alvarez V., Rossetti A.O., Michel P., Kuntzer T., Nater B., Démonet J.F., Schluep M., Du Pasquier R., Vingerhoets F., 2013. Revue Médicale Suisse, 9 (368) pp. 62-65. Peer-reviewed.
[Pmid][serval:BIB_0DFA2D84055B]
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
Pellaton C., Perrin Y., Boudousquié C., Barbier N., Wassenberg J., Corradin G., Thierry A.C., Audran R., Reymond C., Spertini F., 2013. Clinical and Translational Allergy, 3 (1) p. 17.
[URN][DOI][Pmid][serval:BIB_1F03735EDF6D]
 
On s'enflamme tous pour la tête [Head inflammation].
Du Pasquier R.A., Lalive P.H., 2013. Revue Médicale Suisse, 9 (384) p. 907.
[Pmid][serval:BIB_9E3E2897982B]
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.
Metzner K.J., Scherrer A.U., Preiswerk B., Joos B., von Wyl V., Leemann C., Rieder P., Braun D., Grube C., Kuster H. et al., 2013. Journal of Infectious Diseases, 208 (7) pp. 1102-1112.
[URN][DOI][WoS][Pmid][serval:BIB_543A26F20E1F]
 
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner A.M., Corthésy B., Merkle H.P., 2013. Advanced Drug Delivery Reviews, 65 (10) pp. 1386-1399.
[DOI][WoS][Pmid][serval:BIB_0E52C52ECA28]
Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.
Mühlbacher A., Schennach H., van Helden J., Hebell T., Pantaleo G., Bürgisser P., Cellerai C., Permpikul P., Rodriguez M.I., Eiras A. et al., 2013. Medical Microbiology and Immunology, 202 (1) pp. 77-86.
[URN][DOI][WoS][Pmid][serval:BIB_95AE603EC052]
 
Pneumopathie interstitielle granulomato-lymphocytaire dans l'immunodéficience commune variable [Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency].
Prella M., Letovanec I., Spertini F., Nicod L.P., Lazor R., 2013. Revue Médicale Suisse, 9 (407) pp. 2175-2180.
[Pmid][serval:BIB_6BC47993F101]
Polymyalgia rheumatica en 2012.
Buss G., Petitpierre S., Beer D., Zufferey P., Bart P.A., 2013. Forum Médical Suisse, 13 (7) pp. 136-140.
[URN][serval:BIB_0E7ADED9B266]
Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells.
Viganò S., Bellutti Enders F., Miconnet I., Cellerai C., Savoye A.L., Rozot V., Perreau M., Faouzi M., Ohmiti K., Cavassini M. et al., 2013. Plos Pathogens, 9 (7) pp. e1003423.
[URN][DOI][WoS][Pmid][serval:BIB_D20B27FA77D4]
 
Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study.
Simioni S., Cavassini M., Annoni J.M., Métral M., Iglesias K., Rimbault Abraham A., Jilek S., Calmy A., Müller H., Fayet-Mello A. et al., 2013. Neurology, 80 (6) pp. 553-560.
[DOI][WoS][Pmid][serval:BIB_D0BFAE403114]
 
Role of secretory IgA in infection and maintenance of homeostasis.
Corthésy B., 2013. Autoimmunity Reviews, 12 (6) pp. 661-665.
[DOI][WoS][Pmid][serval:BIB_2FEF12342B28]
 
Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.
Herrera D., Vásquez C., Corthésy B., Franco M.A., Angel J., 2013. Human Vaccines and Immunotherapeutics, 9 (11) pp. 2409-2417.
[DOI][WoS][Pmid][serval:BIB_5D04A24689CF]
 
Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice.
Diana J., Moura I.C., Vaugier C., Gestin A., Tissandie E., Beaudoin L., Corthésy B., Hocini H., Lehuen A., Monteiro R.C., 2013. Journal of Immunology, 191 (5) pp. 2335-2343.
[DOI][WoS][Pmid][serval:BIB_356149D09B53]
Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
Schüpbach J., Gebhardt M.D., Scherrer A.U., Bisset L.R., Niederhauser C., Regenass S., Yerly S., Aubert V., Suter F., Pfister S. et al., 2013. Plos One, 8 (8) pp. e71662.
[URN][DOI][WoS][Pmid][serval:BIB_643DBDCA1977]
 
T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.
Utzschneider D.T., Legat A., Fuertes Marraco S.A., Carrié L., Luescher I., Speiser D.E., Zehn D., 2013. Nature Immunology, 14 (6) pp. 603-610.
[DOI][WoS][Pmid][serval:BIB_AE632E10AA6B]
 
The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study.
Spertini F., Audran R., Lurati F., Ofori-Anyinam O., Zysset F., Vandepapelière P., Moris P., Demoitié M.A., Mettens P., Vinals C. et al., 2013. Tuberculosis, 93 (2) pp. 179-188.
[DOI][WoS][Pmid][serval:BIB_2618668010F6]
 
The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes.
Bioley G., Zehn D., Lassus A., Terrettaz J., Tranquart F., Corthésy B., 2013. Biomaterials, 34 (21) pp. 5423-5430.
[DOI][WoS][Pmid][serval:BIB_7AB8BE78D427]
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients.
Beerenwinkel N., Montazeri H., Schuhmacher H., Knupfer P., von Wyl V., Furrer H., Battegay M., Hirschel B., Cavassini M., Vernazza P. et al., 2013. PLOS Computational Biology, 9 (8) pp. e1003203.
[URN][DOI][WoS][Pmid][serval:BIB_CCDA351C1127]
 
Thirty years of HIV: what have we learned?
Cooper D.A., Pantaleo G., 2013. Current Opinion in HIV and Aids, 8 (4) pp. 304-305.
[DOI][WoS][Pmid][serval:BIB_F9A547EBBED2]
 
Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].
Schluep M., Lalive P.H., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 940-943.
[Pmid][serval:BIB_8385AEC5E86A]
 
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.
Marais B.J., Lönnroth K., Lawn S.D., Migliori G.B., Mwaba P., Glaziou P., Bates M., Colagiuri R., Zijenah L., Swaminathan S. et al., 2013. Lancet Infectious Diseases, 13 (5) pp. 436-448.
[DOI][WoS][Pmid][serval:BIB_65DCE96B1D2C]
 
Two Cases of Interferon-Alpha-Induced Sarcoidosis Koebnerized along Venous Drainage Lines: New Pathogenic Insights and Review of the Literature of Interferon-Induced Sarcoidosis.
Buss G., Cattin V., Spring P., Malinverni R., Gilliet M., 2013. Dermatology, 226 (4) pp. 289-297.
[DOI][WoS][Pmid][serval:BIB_C5ABDE4F5C22]
 
Vaccine and immunotherapeutic interventions.
Pantaleo G., Lévy Y., 2013. Current Opinion in Hiv and Aids, 8 (3) pp. 236-242.
[DOI][WoS][Pmid][serval:BIB_5D73CB52384C]
2012
A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.
Pattacini L., Mize G.J., Graham J.B., Fluharty T.R., Graham T.M., Lingnau K., Wizel B., Perdiguero B., Esteban M., Pantaleo G. et al., 2012. Plos One, 7 (7) pp. e42163.
[URN][DOI][WoS][Pmid][serval:BIB_E677EE9F9A8A]
 
Allergie aux beta-lactamines [Allergy to beta-lactam antibiotics].
Comte D., Petitpierre S., Spertini F., Bart P.A., 2012. Revue Médicale Suisse, 8 (337) pp. 836, 838-836, 842.
[Pmid][serval:BIB_3867C9F25CAD]
 
Assessment of melanocytic skin lesions with a high-definition laser Doppler imaging system.
Hunger R.E., Torre R.D., Serov A., Hunziker T., 2012. Skin Research and Technology, 18 (2) pp. 207-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4CAE0C0C5FD6]
Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.
Enouz S., Carrié L., Merkler D., Bevan M.J., Zehn D., 2012. Journal of Experimental Medicine, 209 (10) pp. 1769-1779.
[URN][DOI][WoS][Pmid][serval:BIB_AE177F209BFD]
 
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Schmidt C., Smith C., Barin B., Bakhtyari A., Bart P.A., Bekker L.G., Chomba E., Clumeck N., Ho D., Hoosen A. et al., 2012. Human Vaccines and Immunotherapeutics, 8 (5) pp. 630-638.
[DOI][WoS][Pmid][serval:BIB_3528513AE54B]
Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10.
Marek D., Papin S., Ellefsen K., Niederhauser J., Isidor N., Ransijn A., Poupon L., Spertini F., Pantaleo G., Bergmann S. et al., 2012. Journal of Neuroinflammation, 9 p. 238. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ADF180AFD031]
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
Perdiguero B., Gómez C.E., Nájera J.L., Sorzano C.O., Delaloye J., González-Sanz R., Jiménez V., Roger T., Calandra T., Pantaleo G. et al., 2012. Plos One, 7 (10) pp. e48524. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA881424A3B7]
 
Estimating the basic reproductive number from viral sequence data.
Stadler T., Kouyos R., von Wyl V., Yerly S., Böni J., Bürgisser P., Klimkait T., Joos B., Rieder P., Xie D. et al., 2012. Molecular Biology and Evolution, 29 (1) pp. 347-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6727E799CE03]
 
Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control.
Schwab N., Ulzheimer J.C., Fox R.J., Schneider-Hohendorf T., Kieseier B.C., Monoranu C.M., Staugaitis S.M., Welch W., Jilek S., Du Pasquier R.A. et al., 2012. Neurology, 78 (7) pp. 458-467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B7DBDB2E020]
 
FluxEXPLORER: a new high-speed laser Doppler imaging system for the assessment of burn injuries.
Erba P., Espinoza D., Koch N., Christen T., Serov A., Raffoul W., 2012. Skin Research and Technology, 18 (4) pp. 456-461.
[DOI][WoS][Pmid][serval:BIB_A37BB54D3332]
Functional avidity: a measure to predict the efficacy of effector T cells?
Viganò S., Utzschneider D.T., Perreau M., Pantaleo G., Zehn D., Harari A., 2012. Clinical and Developmental Immunology, 2012 p. 153863. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B0CB84A1CD5B]
Gammapathies monoclonales: Utilisation des chaînes légères libres sériques.
Aubert V., Duchosal M.A., 2012. Swiss Medical Forum, 12 (29) pp. 576-577.
[URN][serval:BIB_35719C47A1D5]
 
Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses.
Bioley G., Lassus A., Bussat P., Terrettaz J., Tranquart F., Corthésy B., 2012. Biomaterials, 33 (25) pp. 5935-5946.
[DOI][WoS][Pmid][serval:BIB_A5FEA16169DF]
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.
Siegrist C.A., van Delden C., Bel M., Combescure C., Delhumeau C., Cavassini M., Clerc O., Meier S., Hadaya K., Soccal P.M. et al., 2012. Plos One, 7 (7) pp. e40428. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2314A746CDE2]
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital
Darling K.E., Hugli O., Mamin R., Cellerai C., Martenet S., Berney A., Peters S., Du Pasquier R.A., Bodenmann P., Cavassini M., 2012. Plos One, 7 (6) pp. e39299. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E065FD76F59C]
 
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Jilek S., Schluep M., Harari A., Canales M., Lysandropoulos A., Zekeridou A., Pantaleo G., Du Pasquier R.A., 2012. Journal of Immunology, 188 (9) pp. 4671-4680. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0D2159CC0F6]
 
Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C., Pache I., Bürgisser P., Elzi L., Darling K.E., Cavassini M., 2012. Journal of Infection, 65 (2) pp. 157-164.
[DOI][WoS][Pmid][serval:BIB_7D286B3CF16D]
 
Immunodéficience commune variable: ce qu'il faut savoir [Common variable immune deficiency: what you need to know].
Buss G., Comte D., Spertini F., Bart P.A., Petitpierre S., 2012. Revue Médicale Suisse, 8 (337) pp. 859-864.
[Pmid][serval:BIB_267159E0AF97]
 
Immunological and clinical consequences of treating a patient with natalizumab.
Schwab N., Höhn K.G., Schneider-Hohendorf T., Metz I., Stenner M.P., Jilek S., Du Pasquier R.A., Gold R., Meuth S.G., Ransohoff R.M. et al., 2012. Multiple Sclerosis, 18 (3) pp. 335-344. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41CCB1BCBDCD]
 
Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P., Manuel O., 2012. Transplantation, 94 (6) pp. 630-636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50AE47EF9B4C]
 
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Antoniol C., Jilek S., Schluep M., Mercier N., Canales M., Le Goff G., Campiche C., Pantaleo G., Du Pasquier R.A., 2012. Neurology, 79 (23) pp. 2258-2264.
[DOI][WoS][Pmid][serval:BIB_703F31D7E9A0]
 
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.
Vardas E., Stanescu I., Leinonen M., Ellefsen K., Pantaleo G., Valtavaara M., Ustav M., Reijonen K., 2012. Vaccine, 30 (27) pp. 4046-4054.
[DOI][WoS][Pmid][serval:BIB_AB309B04B63D]
Inferring epidemic contact structure from phylogenetic trees.
Leventhal G.E., Kouyos R., Stadler T., von Wyl V., Yerly S., Böni J., Cellerai C., Klimkait T., Günthard H.F., Bonhoeffer S., 2012. Plos Computational Biology, 8 (3) pp. e1002413.
[URN][DOI][WoS][Pmid][serval:BIB_BAAFB38A1551]
Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice.
Pellaton C., Nutten S., Thierry A.C., Boudousquié C., Barbier N., Blanchard C., Corthésy B., Mercenier A., Spertini F., 2012. International Journal of Inflammation, 2012 (686739) pp. 1-8.
[URN][DOI][Pmid][serval:BIB_FB14579C8D6E]
 
Les allergies médicamenteuses, une hydre à neuf têtes.. [Drug allergies].
Spertini F., Seebach J.D., 2012. Revue Médicale Suisse, 8 (337) pp. 827-828.
[Pmid][serval:BIB_405A82989897]
Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.
Scherrer A.U., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H., Calmy A., Cavassini M., Elzi L., Vernazza P.L. et al., 2012. Plos One, 7 (11) pp. e50307.
[URN][DOI][WoS][Pmid][serval:BIB_35E3BFD66909]
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
Scherrer A.U., Ledergerber B., von Wyl V., Böni J., Yerly S., Klimkait T., Cellerai C., Furrer H., Calmy A., Cavassini M. et al., 2012. Plos One, 7 (6) pp. e37983.
[URN][DOI][WoS][Pmid][serval:BIB_EE38A930BCD4]
 
Modulation of human memory T-cell function by different antigen-presenting cells.
Perreau M., Welles H.C., Harari A., Calandra T., Roger T., Pantaleo G., 2012. European Journal of Immunology, 42 (3) pp. 799-802.
[DOI][WoS][Pmid][serval:BIB_426696050FC2]
 
Mycobacterium tuberculosis-specific CD8 T cells are functionally and phenotypically different between latent infection and active disease
Rozot V., Vigano S., Mazza-Stalder J., Perreau M., Goletti D., Bart P. A., Nicod L., Pantaleo G., Harari A., 2012. p. 598 dans European Congress of Immunology, Immunology.
[WoS][serval:BIB_D7303CF13CEC]
 
Neurologie [Neurology].
Chabwine J.N., Rossetti A.R., Hirt L., Kuntzer T., Schluep M., Michel P., Démonet J.F., du Pasquier R.A., Vingerhoets F.G., 2012. Revue Médicale Suisse, 8 (323) pp. 46-50. Peer-reviewed.
[Pmid][serval:BIB_2E4541BC9980]
 
Nonrandom Distribution of Cryptic Repeating Triplets of Purines and Pyrimidines (RNY)(n) in gp120 of HIV Type1.
De Crignis E., Guglietta S., Foley B.T., Negroni M., Di Narzo A.F., Waelti Da Costa V., Cavassini M., Bart P.A., Pantaleo G., Graziosi C., 2012. Aids Research and Human Retroviruses, 28 (5) pp. 493-504.
[DOI][WoS][Pmid][serval:BIB_E7E373E5CDE0]
 
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Harari A., Rozot V., Cavassini M., Enders F.B., Vigano S., Tapia G., Castro E., Burnet S., Lange J., Moog C. et al., 2012. European Journal of Immunology, 42 (11) pp. 3038-3048.
[DOI][WoS][Pmid][serval:BIB_0D93650C7F77]
 
Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M.
Scherrer A.U., von Wyl V., Götte M., Klimkait T., Cellerai C., Yerly S., Böni J., Held L., Ledergerber B., Günthard H.F. et al., 2012. Journal of Acquired Immune Deficiency Syndromes, 59 (2) pp. 105-112.
[DOI][WoS][Pmid][serval:BIB_9C1A5E8F92FD]
Positive and negative regulation of cellular immune responses in physiologic conditions and diseases.
Viganò S., Perreau M., Pantaleo G., Harari A., 2012. Clinical and Developmental Immunology, 2012 p. 485781.
[URN][DOI][WoS][Pmid][serval:BIB_4F81E9CDB066]
 
Prevalence of beryllium sensitization in patients diagnosed with sarcoidosis
Lazor Romain, Aubert Vincent, Dorribo Victor, Chagnon Krief Peggy, Ottesen Montangero Sandrine, Wild Pascal, Bieler Gilles, Geiser Thomas, Valeyre Dominique, Berode Michèle et al., 2012. pp. 659S dans ERS 22nd Annual Congress, Vienna, Austria 1-5 September 2012, European Respiratory Journal.
[serval:BIB_75D4A641B788]
 
Probing the T-cell receptor repertoire with deep sequencing.
Miconnet I., 2012. Current Opinion In Hiv and Aids, 7 (1) pp. 64-70.
[DOI][WoS][Pmid][serval:BIB_6DB680DC3B78]
 
Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia.
Chabwine J.N., Lhermitte B., Da Silva M.O., Buss G., Maeder P., Du Pasquier R.A., 2012. Neurology, 78 (24) pp. 2000-2002.
[DOI][WoS][Pmid][serval:BIB_E1293A6E72CF]
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.
Stravodimou A., Cairoli A., Rausch T., Du Pasquier R., Michel P., 2012. Case Reports In Medicine, 2012 p. 239719.
[URN][DOI][Pmid][serval:BIB_AB92C502EDD1]
Research needs in allergy: an EAACI position paper, in collaboration with EFA.
Papadopoulos N.G., Agache I., Bavbek S., Bilo B.M., Braido F., Cardona V., Custovic A., Demonchy J., Demoly P., Eigenmann P. et al., 2012. Clinical and Translational Allergy, 2 (1) pp. 1-23. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_15B7FAFBA2F3]
 
Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
Schluep M., Du Pasquier R., 2012. Revue Médicale Suisse, 8 (339) pp. 946-949.
[Pmid][serval:BIB_74AFB87DCACD]
 
Selectively expanding subsets of T cells in mice by injection of interleukin-2/antibody complexes: implications for transplantation tolerance.
Boyman O., Krieg C., Letourneau S., Webster K., Surh C.D., Sprent J., 2012. Transplantation Proceedings, 44 (4) pp. 1032-1034.
[DOI][WoS][Pmid][serval:BIB_83B6300AE872]
 
Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide.
Langenskiöld E., Bonetti A., Fitting J.W., Heinzer R., Dudler J., Spertini F., Lazor R., 2012. Respiration, 84 (2) pp. 144-149.
[DOI][WoS][Pmid][serval:BIB_2818C5D8AE61]
 
Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts.
Hafner A.M., Burschowsky D., Corthésy B., Textor M., Merkle H.P., 2012. Journal of Controlled Release, 159 (2) pp. 204-214.
[DOI][WoS][Pmid][serval:BIB_CF55965FC2B8]
 
Syndrome de Sjögren: enfin une nouvelle approche de traitement [Sjögren's syndrome: a new approach to treatment].
Rossier V., Bart P.A., Spertini F., 2012. Revue Médicale Suisse, 8 (337) pp. 843-847.
[Pmid][serval:BIB_1ED13D02C38D]
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
Gómez C.E., Perdiguero B., Jiménez V., Filali-Mouhim A., Ghneim K., Haddad E.K., Quakkelaar E.D., Quakkerlaar E.D., Delaloye J., Harari A. et al., 2012. Plos One, 7 (4) pp. e35485.
[URN][DOI][WoS][Pmid][serval:BIB_C791C445724A]
 
Systems biology in the development of HIV vaccines.
Haddad E.K., Pantaleo G., 2012. Current Opinion In Hiv and Aids, 7 (1) pp. 44-49. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9A012FB0528]
 
T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology.
King C.G., Koehli S., Hausmann B., Schmaler M., Zehn D., Palmer E., 2012. Immunity, 37 (4) pp. 709-720. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC44163FA6B2]
TCR signaling requirements for activating T cells and for generating memory.
Zehn D., King C., Bevan M.J., Palmer E., 2012. Cellular and Molecular Life Sciences, 69 (10) pp. 1565-1575.
[URN][DOI][WoS][Pmid][serval:BIB_783B78F0E814]
 
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes.
Perreau M., Welles H.C., Pellaton C., Gjoksi B., Potin L., Martin R., Harari A., Bett A., Casimiro D., Gall J. et al., 2012. Journal of Virology, 86 (11) pp. 6279-6285.
[DOI][WoS][Pmid][serval:BIB_B4299141A4E6]
 
The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells.
Bioley G., Bussat P., Lassus A., Schneider M., Terrettaz J., Corthésy B., 2012. Biomaterials, 33 (1) pp. 333-342.
[DOI][WoS][Pmid][serval:BIB_A620A687AA34]
 
The Role of Secretory Immunoglobulin A in the Natural Sensing of Commensal Bacteria by Mouse Peyer's Patch Dendritic Cells.
Rol N., Favre L., Benyacoub J., Corthésy B., 2012. Journal of Biological Chemistry, 287 (47) pp. 40074-40082.
[DOI][WoS][Pmid][serval:BIB_21F946514C74]
 
Toll-Interacting Protein Modulates Gut Flora Composition, Epithelial Barrier Integrity and Susceptibility to Colitis
Maillard M.H., Grandjean T., Uhlig H.H., Barnich N., Longet S., Corthésy B., Michetti P., Chamaillard M., Velin D., 2012. dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association of the Study of the Liver and Swiss Society of Clinical Nutrition, Swiss Medical Weekly.
[serval:BIB_8253C695E8CA]
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
McNerney R., Maeurer M., Abubakar I., Marais B., McHugh T.D., Ford N., Weyer K., Lawn S., Grobusch M.P., Memish Z. et al., 2012. Journal of Infectious Diseases, 205 (Suppl. 2) pp. S147-S158.
[URN][DOI][WoS][Pmid][serval:BIB_F65424B09DBF]
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Ludigs K., Parfenov V., Du Pasquier R.A., Guarda G., 2012. Cellular and Molecular Life Sciences, 69 (20) pp. 3395-3418. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A93C669EA17D]
 
Uvéite antérieure et cataracte chez une enfant de 12 mois après vaccination pour la rubéole
Ferrini W., Aubert V., Balmer A., Munier F., Abou Zeid H., 2012., Société Suisse d'Ophtalmologie pp. S107 dans Ophta.
[serval:BIB_A98F52CD419C]
2011
 
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease.
Harari A., Rozot V., Bellutti Enders F., Perreau M., Mazza-Stalder J.M., Nicod L.P., Cavassini M., Calandra T., Blanchet C.L., Jaton K. et al., 2011/03. Nature medicine, 17 (3) pp. 372-376. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C47C605FFBCF]
 
A Phase IIB, Randomized, Double-Blind, Multicenter, Immunogenicity Study of Vacc-4x Versus Placebo in HIV-1-infected Patients
Rockstroh J.K., Pantaleo G., Pollard R., van Lunzen J., Asmuth D., Peters B., Podzamczer D., Lazzarin A., Ellefsen-Lavoie K., Baksaas I. et al., 2011. pp. A129-A130 dans AIDS Vaccine 2011 Conference, Aids Research and Human Retroviruses. Peer-reviewed.
[WoS][serval:BIB_A89095C1B5AA]
 
Allergie aux venins d'hyménopteres: nouveautés diagnostiques et prise en charge [Hymenoptera venom allergy: new diagnostic tools and management].
Comte D., Petitpierre S., Bart P.A., Spertini F., Leimgruber A., 2011. Revue Médicale Suisse, 7 (291) pp. 844-849.
[Pmid][serval:BIB_4870E9EAE1B3]
 
Allergo-immunologie. 1. Nouveautés dans le traitement des crises aiguës d'angioedème héréditaire [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
Leimgruber A., 2011. Revue Médicale Suisse, 7 (278) pp. 103-105.
[Pmid][serval:BIB_7D0E95F1F1E0]
 
Allergo-immunologie. 2. Faut-il se méfier des agents biologiques [Allergy-immunology. Do we have to be afraid of biological agents?].
Bart P.A., 2011. Revue Médicale Suisse, 7 (278) pp. 106-107.
[Pmid][serval:BIB_5E2E3F136B15]
 
Anti-inflammatory properties of secretory IgA on intestinal epithelial cells during infection by Shigella flexneri
Mathias A., Corthesy B., 2011. p. 99 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
[WoS][serval:BIB_4D87148D9978]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University